chartexchange

MCRB
Seres Therapeutics, Inc.
stockNASDAQ

Market OpenNov 16, 2026 9:38:52 AM EST
1.60USD+14.286%(+0.20)19,200
1.2800Bid1.8300Ask0.5500Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$1.39
Beta
1.30
52-Week High
$29.98 2025-11-20
52-Week Low
$1.30 2026-11-12
SMA 50
$2.96
SMA 200
$6.43
Avg. Vol 10D
96,737
Avg. Vol 30D
83,444
Avg. Vol 90D
75,420
Relative Vol
0.23
7.79M
1.5000%
10,229
Apr 22, 2025 · 1-for-20 (reverse)
MCRB Profile

seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.

MCRB Performance
PeriodPriceDateChangeBeta
1W1.702026-11-09-6.59%0.678
1M2.462026-10-16-35.45%-0.400
3M4.512026-08-17-64.79%0.425
6M7.642026-05-15-79.22%0.406
1Y21.642025-11-17-92.66%1.304
2Y10.992024-11-15-85.56%—
5Y163.602021-11-16-99.03%1.194
MCRB Stock Summary

Seres Therapeutics, Inc. (NASDAQ:MCRB) stock price today is $1.59, and today's volume is 18,970. MCRB is up 13.421% today. The 30 day average volume is 83,444. MCRB market cap is $16.19M with 10.20M shares outstanding.